Brain+ A/S Share Price

Equities

BRAINP

DK0061670205

Software

Market Closed - Nasdaq Copenhagen 08:20:18 03/05/2024 pm IST 5-day change 1st Jan Change
0.1285 DKK +7.53% Intraday chart for Brain+ A/S -0.77% -33.76%

Financials

Sales 2017 4.34M 627K 52.29M Sales 2018 6.08M 878K 73.26M Capitalization 11.76M 1.7M 142M
Net income 2017 - 0 0 Net income 2018 - 0 0 EV / Sales 2017 * -
Net cash position 2017 * - 0 0 Net cash position 2018 * - 0 0 EV / Sales 2018 * -
P/E ratio 2017 *
-
P/E ratio 2018 *
-
Employees 20
Yield 2017 *
-
Yield 2018 *
-
Free-Float 43.86%
More Fundamentals * Assessed data
Dynamic Chart
Certain Shares of Brain+ A/S are subject to a Lock-Up Agreement Ending on 22-APR-2024. CI
Brain+ Teams Up with Quiddity Health to Launch Cognitive Stimulation Therapy Software in UK MT
Brain+ A/S Partners with Quiddity Health to Prepare UK Market Entry for CST-Therapist Companion CI
Brain+ Bags Two Cognitive Stimulation Therapy Software Supply Deals in Denmark MT
Brain+ Signs Two New Danish Sales Contracts on CST-Therapist Companion and Updates on the Product's Commercial Potential CI
Brain+ Names Interim CFO to Permanent Role MT
Brain+ A/S Announces CFO Changes CI
Brain+ A/S Announces Resignation of Anders Härfstrand as Chairman and Member of the Board, Effective from January 31, 2024 CI
Brain+ Receives DKK4 Million Grant in Denmark for Digital Therapy Platform for Dementia Support MT
Brain+ to Supply Cognitive Stimulation Therapy Software to Care Facilities in Copenhagen, Denmark MT
Brain+ A/S Closes Sales Contract with Copenhagen Municipality on CST-Therapist Companion to Support Dementia Care and Therapy CI
Brain+ Nominates to CO-PI Grant of Up to DKK 3.5 Million from Denmark's Business Promotion Board CI
Brain+ Launches Usability Study in Denmark for Cognitive Stimulation Therapy Therapist Companion Platform MT
Brain+ A/S and VIA University College start usability study on CST-Therapist Companion in Denmark CI
Brain+ A/S Announces Resignation of Betül Susamis Unaran, Member of the Board of Directors, Effective on 30 November CI
More news
1 day+7.53%
1 week-0.77%
Current month-1.53%
1 month-11.38%
3 months-18.15%
6 months-42.38%
Current year-33.76%
More quotes
1 week
0.12
Extreme 0.115
0.14
1 month
0.11
Extreme 0.11
0.16
Current year
0.11
Extreme 0.11
0.22
1 year
0.11
Extreme 0.11
1.00
3 years
0.11
Extreme 0.11
5.10
5 years
0.11
Extreme 0.11
5.10
10 years
0.11
Extreme 0.11
5.10
More quotes
Managers TitleAgeSince
Founder - 17/12/17
Chief Executive Officer - 17/12/17
Director of Finance/CFO 59 01/21/01
Members of the board TitleAgeSince
Director of Finance/CFO 59 01/21/01
Director/Board Member 65 02/22/02
More insiders
Brain+ A/S is a Denmark-based software company primarily engaged in developing medical software. The Company focuses on the development of digital treatment for dementia and Alzheimer’s disease by digital therapeutics. The Company’s main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimer’s and Starry Night memory test for early detection and monitoring of Alzheimer’s. It offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.
More about the company
  1. Stock Market
  2. Equities
  3. BRAINP Stock